In vitro determination of radiation sensitivity parameters for DU-145 prostate cancer cells

International Journal of Radiation Biology

Volumn 84, Issue 6, 2008, Pages 515-522

  Wang, Jian Z ^a,e   Rhee, Juong G ^b   Shi, Peipei ^a   Stewart, Robert D ^c   Allen Li, X ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c PURDUE UNIVERSITY   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

In vitro measurement; Linear quadratic model; Prostrate cancer; Repair half time

Indexed keywords

ARTICLE; CANCER CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOSENSITIVITY; X RAY;

CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 45849146610     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000802061285     Document Type: Article

References (28)

1. Algan O, Stobbe CC, Helt AM, Hanks GE, Chapman JD. 1996. Radiation inactivation of human prostate cancer cells: The role of apoptosis. Radiation Research 146:267-275.
2. Brenner DJ, Hall EJ. 1999. Fractionation and protraction for radiotherapy of prostate carcinoma. International Journal of Radiation Oncology Biology Physics 43:1095-1101.
3. Brenner DJ, Hall EJ. 2000. In response to Drs. King and Mayo: Low a/b values for prostate appear to be independent of modeling details [letter]. International Journal of Radiation Oncology Biology Physics 47:538-539.
4. Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. 2002. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. International Journal of Radiation Oncology Biology Physics 52:6-15.
5. Carlson DJ, Stewart RD, Li XA, Jennings K, Wang JZ, Guerrero M. 2004. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Physics in Medicine and Biology 49:4477-4491.
6. Dale RG, Fowler JF, Jones B. 1999. A new incomplete-repair model based on a 'reciprocal-time' pattern of sublethal damage repair. Acta Oncologica 38:919-929.
7. DeWeese TL, Shipman JM, Dillehay LE, Nelson WG. 1998. Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. Journal of Urology 159:591-598.
8. Fowler J, Chappell R, Ritter M. 2001. Is alpha/beta for prostate tumors really low? International Journal of Radiation Oncology Biology Physics 50:1021-1031.
9. Fowler JF. 2002. Repair between dose fractions: A simpler method of analyzing and reporting apparently biexponential repair. Radiation Research 158:141-151.
10. Fowler JF, Welsh JS, Howard SP. 2004. Loss of biological effect in prolonged fraction delivery. International Journal of Radiation Oncology Biology Physics 59:242-249.
11. Garcia LM, Leblanc J, Wilkins D, Raaphorst GP. 2006. Fitting the linear-quadratic model to detailed data sets for different dose ranges. Physics in Medicine and Biology 51:2813-2823.
12. Garcia LM, Wilkins DE, Raaphorst GP. 2007. Alpha/beta ratio: A dose range dependence study. International Journal of Radiation Oncology Biology Physics 67:587-593.
13. Guerrero M, Stewart RD, Wang JZ, Li XA. 2002. Equivalence of the linear-quadratic and two-lesion kinetic models. Physics in Medicine and Biology 47:3197-3209.
14. Kal HB, Van Gellekom MP. 2003. How low is the alpha/beta ratio for prostate cancer? International Journal of Radiation Oncology Biology Physics 57:1116-1121.
15. King CR, Mayo CS. 2000. Is the prostrate alpha/beta ratio of 1.5 from Brenner & Hall a modeling artifact. International Journal of Radiation Oncology Biology Physics 47:536-539.
16. Leith JT, Quaranto L, Padfield G, Michelson S, Hercbergs A. 1993. Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: X-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo. International Journal of Radiation Oncology Biology Physics 25:283-287.
17. Mogili N, Joiner M, Burmeister J. 2006. Effects of IMR treatment time prolongation on tumor cell survival. Medical Physics 33:2294.
18. Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Greenberg RE, Stobbe C, et al. 2002. Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. Urology 60:634-639.
19. Mu X, Lofroth PO, Karlsson M, Zackrisson B. 2003. The effect of fraction time in intensity modulated radiotherapy: Theoretical and experimental evaluation of an optimisation problem. Radiotherapy and Oncology 68:181-187.
20. Ogino H, Shibamoto Y, Sugie C, Ito M. 2005. Biological effects of intermittent radiation in cultured tumor cells: Influence of fraction number and dose per fraction. Journal of Radiation Research (Tokyo) 46:401-406.
21. Paganetti H. 2005. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy. International Journal of Radiation Oncology Biology Physics 63:892-900.
22. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. 2002. Confidence limits on estimated model parameters. In: Numerical recipes in C. 2nd ed. Cambridge, UK: Cambridge University Press. p 689-699.
23. Shibamoto Y, Ito M, Sugie C, Ogino H, Hara M. 2004. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: Implications for dose modification in radiosurgery and IMRT. International Journal of Radiation Oncology Biology Physics 59:1484-1490.
24. Wang JZ, Guerrero M, Li XA. 2003a. How low is the α/β ratio for prostate cancer? International Journal of Radiation Oncology Biology Physics 55: 194-203.
25. Wang JZ, Li XA, D'Souza WD, Stewart RD. 2003b. Impact of prolonged fraction delivery times on tumor control: A note of caution for intensity-modulated radiation therapy (IMRT). International Journal of Radiation Oncology Biology Physics 57:543-552.
26. Wang JZ, Li XA, Yu CX, DiBiase SJ. 2003c. The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us? International Journal of Radiation Oncology Biology Physics, 57: 1101-1108.
27. Wang JZ, Mayr NA, Li XA, Stewart RD. 2005. Modeling prostate cancer: in regards to Nahum et al. [letter]. International Journal of Radiation Oncology Biology Physics 61:309-310.
28. Wang JZ, Li XA, Mayr NA. 2006. Dose escalation to combat hypoxia in prostate cancer: A radiobiological study on clinical data. British Journal of Radiology 79:905-911.